⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARVN News
Arvinas, Inc
Arvinas Announces Return of Early Career Researcher Award to Recognize Innovation in Targeted Protein Degradation
globenewswire.com
ARVN
Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026
globenewswire.com
ARVN
Metastatic HR+/HER2- Breast Cancer - Market Insights, Epidemiology, Competitive Landscape, and Market Forecast - 2036 | 8% CAGR Fueled by Oral SERDs, ADCs, and Targeted Therapies
globenewswire.com
PFE
LLY
AZN
GILD
MRK
ARVN
OMER
CELC
BNTX
FHLB Dallas and Arvest Bank Celebrate the Grand Opening of Senior Housing Complex in Harrison, Arkansas, Helped by $1.5M Affordable Housing Grant
businesswire.com
ARVN
Media Advisory: FHLB Dallas and Arvest Bank to Celebrate Opening of Harrison Estates Senior Housing in Harrison, Arkansas, Assisted with $1.5M Grant
businesswire.com
ARVN
Media Advisory: FHLB Dallas and Arvest Bank to Celebrate Opening of Harrison Estates Senior Housing in Harrison, Arkansas, Assisted with $1.5M Grant
businesswire.com
ARVN
Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease
globenewswire.com
ARVN
Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®
globenewswire.com
ARVN
Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ARVN
Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate
globenewswire.com
ARVN